Raaj Medisafe board approves FY26 audited financial results

Raaj Medisafe India Limited's board has approved the audited financial results for the quarter and year ended March 31, 2026. The meeting, held on May 29, 2026, also authorized the submission of financial statements and related party transactions to BSE.

The board approved the financial statements and cash flow statement for the year ended March 31, 2026. Additionally, the directors considered and approved transactions with related parties entered into by the company between October 1, 2025, and March 31, 2026.

The board also took note of the draft auditors' report on the financial statements for the year ended March 31, 2026. The audited financial results, cash flow statement, and statement of assets and liabilities as of March 31, 2026, were taken on record and authorized for submission to the exchange.

Other key approvals included the integrated finance report for the quarter and year ended March 31, 2026. This report includes particulars of related party transactions and a statement on the utilization of funds raised through preferential allotment.

The board authorized the registrar and transfer agent (RTA) to direct the conversion of physical shares to demat form as per a SEBI circular dated January 30, 2026. The reconciliation of share capital audit for the quarter ended March 31, 2026, was also adopted.

The shareholding pattern and the integrated governance report, which includes the investor grievance and redressal report for the quarter ended March 31, 2026, were taken on record.

Business Transacted	Outcome
Minutes of previous Board and committee meetings	Noted and Confirmed
Related party transactions (Oct 1, 2025 to Mar 31, 2026)	Considered and approved
Financial Statements and Cash Flow Statement for FY26	Considered and approved
Draft Auditors Report on Financial Statements for FY26	Noted
Audited Financial Results and Cash Flow Statement for Q4 and FY26	Considered and taken on record
RTA authorization for physical to demat share conversion	Approved
Integrated (Finance) Report for Q4 and FY26	Approved
Reconciliation of Share Capital Audit for Q4FY26	Adopted
Shareholding Pattern for Q4FY26	Taken on record
Integrated (Governance) Report for Q4FY26	Taken on record

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
0.0%	-10.29%	-15.23%	+5.65%	-1.30%	+393.49%

Raaj Medisafe India Limited has announced that its board of directors will meet on May 29, 2026, to discuss and approve the company's financial performance for the fiscal year ending March 31, 2026. The meeting is scheduled to take place at 3:00 P.M. at the company's registered office in Ujjain.

Agenda for the Meeting

The primary focus of the meeting will be the consideration and approval of the audited financial results for the quarter and year ended March 31, 2026. The board will also review the financial statements and cash flow statements for the same period. Furthermore, the directors will take note of the draft auditors' report on the financial statements.

Other Key Business Items

In addition to the financial results, the board will consider and approve transactions with related parties entered into during the period from October 1, 2025, to March 31, 2026. The meeting will also cover the adoption of the Integrated (Finance) Report, which includes details on related party transactions and the utilization of funds raised through preferential allotment.

Governance and Compliance

The board is set to authorize the Registrar and Transfer Agents (RTA) to facilitate the conversion of physical shares into dematerialized form as per a SEBI circular dated January 30, 2026. Other agenda items include adopting the Reconciliation of Share Capital Audit and reviewing the Shareholding Pattern and Integrated (Governance) Report for the quarter ended March 31, 2026.